Skip to Content

121 Results Found

  • Article
  • Open Access
793 Views
13 Pages

Engineered Trivalent Human IgG1-Fc Proteins for Potent Complement Inhibition

  • Ian K. Campbell,
  • Daniel Ortiz,
  • Carlos Bosques,
  • Matthew P. Hardy and ,
  • Andrea Tester,
  • Vesna Tomasetig,
  • Daniel Couto,
  • Thomas Gentinetta,
  • Sabine Pestel and
  • Rolf Spirig
  • + 7 authors+ 2 authors

25 June 2026

High-dose intravenous immunoglobulin (IVIG) is used to treat autoimmune and inflammatory diseases, and several studies demonstrate that the therapeutic effects of IVIG can be recapitulated with the fragment crystallizable (Fc) portion. Further, recen...

(This article belongs to the Special Issue Autoimmune Diseases: Immune Cells and Genetic and Epigenetic Regulations)
  • Article
  • Open Access
9 Citations
2,446 Views
13 Pages

Humoral Responses Elicited by SARS-CoV-2 mRNA Vaccine in People Living with HIV

  • Lorie Marchitto,
  • Debashree Chatterjee,
  • Shilei Ding,
  • Gabrielle Gendron-Lepage and ,
  • Alexandra Tauzin,
  • Marianne Boutin,
  • Mehdi Benlarbi,
  • Halima Medjahed,
  • Mohamed Sylla and
  • Cécile Tremblay
  • + 8 authors+ 3 authors

26 September 2023

While mRNA SARS-CoV-2 vaccination elicits strong humoral responses in the general population, humoral responses in people living with HIV (PLWH) remain to be clarified. Here, we conducted a longitudinal study of vaccine immunogenicity elicited after...

(This article belongs to the Special Issue SARS-CoV-2: Vaccine Design and Host Immunity)
  • Article
  • Open Access
1 Citations
5,574 Views
15 Pages

Enhancing the Total Terminal Galactosylation of CHO Cell-Derived TNF-α Blocker-IgG1 Monoclonal Antibody Using Time-Dependent Galactose Supplementation

  • Mallikarjuna Pulipeta,
  • Pradeep Kumar Iyer,
  • Rajendra Kumar Palakurthy,
  • Narasimha Pullaguri and ,
  • Rajasekhar Pinnamaneni and
  • Srinivas Reddy Chilukuri
  • + 1 author+ 0 author

Background: Recombinant monoclonal antibodies represent a vital category of biologics, constituting the largest class of molecules used to treat autoimmune disorders, cancers, rheumatoid arthritis, and other chronic conditions. The IgG1 subclass is t...

  • Article
  • Open Access
12 Citations
4,349 Views
22 Pages

Protective Efficacy of Lectin-Fc(IgG) Fusion Proteins In Vitro and in a Pulmonary Aspergillosis In Vivo Model

  • Claudia Rodriguez-de la Noval,
  • Susana Ruiz Mendoza,
  • Diego de Souza Gonçalves,
  • Marina da Silva Ferreira and ,
  • Leandro Honorato,
  • José Mauro Peralta,
  • Leonardo Nimrichter and
  • Allan J. Guimarães
  • + 3 authors+ 0 author

27 October 2020

Aspergillosis cases by Aspergillus fumigatus have increased, along with fungal resistance to antifungals, urging the development of new therapies. Passive immunization targeting common fungal antigens, such as chitin and β-glucans, are promising...

(This article belongs to the Special Issue Monoclonal Antibodies as Tools to Diagnose and Treat Fungal Infection)
  • Article
  • Open Access
6 Citations
5,410 Views
18 Pages

Preclinical Characterization of Efficacy and Pharmacodynamic Properties of Finotonlimab, a Humanized Anti-PD-1 Monoclonal Antibody

  • Yunqi Yao,
  • Xiaoning Yang,
  • Jing Li,
  • Erhong Guo and ,
  • Huiyu Wang,
  • Chunyun Sun,
  • Zhangyong Hong,
  • Xiao Zhang,
  • Jilei Jia and
  • Liangzhi Xie
  • + 11 authors+ 6 authors

12 March 2025

Background/Objectives: Finotonlimab (SCTI10A) is a humanized anti-PD-1 antibody tested in Phase III trials for several solid tumor types. Methods: This study characterized the in vitro and in vivo efficacy, Fc-mediated effector function, and non-clin...

(This article belongs to the Section Biopharmaceuticals)
  • Review
  • Open Access
22 Citations
6,535 Views
15 Pages

Structural Basis for Epitopes in the gp120 Cluster A Region that Invokes Potent Effector Cell Activity

  • William D. Tolbert,
  • Rebekah T. Sherburn,
  • Verna Van and
  • Marzena Pazgier

16 January 2019

While a number of therapeutic options to control the progression of human immunodeficiency virus (HIV-1) now exist, a broadly effective preventive vaccine is still not available. Through detailed structural analysis of antibodies able to induce poten...

(This article belongs to the Special Issue HIV Vaccines)
  • Article
  • Open Access
35 Citations
10,659 Views
13 Pages

Dynamic Views of the Fc Region of Immunoglobulin G Provided by Experimental and Computational Observations

  • Saeko Yanaka,
  • Rina Yogo,
  • Rintaro Inoue,
  • Masaaki Sugiyama and ,
  • Satoru G. Itoh,
  • Hisashi Okumura,
  • Yohei Miyanoiri,
  • Hirokazu Yagi,
  • Tadashi Satoh and
  • Koichi Kato
  • + 6 authors+ 1 author

The Fc portion of immunoglobulin G (IgG) is a horseshoe-shaped homodimer, which interacts with various effector proteins, including Fcγ receptors (FcγRs). These interactions are critically dependent on the pair of N-glycans packed between...

(This article belongs to the Special Issue Structure and Function of Antibodies)
  • Review
  • Open Access
54 Citations
25,395 Views
10 Pages

Engineering IgG-Like Bispecific Antibodies—An Overview

  • Simon Krah,
  • Harald Kolmar,
  • Stefan Becker and
  • Stefan Zielonka

1 August 2018

Monoclonal antibody therapeutics have proven to be successful treatment options for patients in various indications. Particularly in oncology, therapeutic concepts involving antibodies often rely on the so-called effector functions, such as antibody...

  • Review
  • Open Access
1 Citations
9,141 Views
11 Pages

In Vivo Secretion of Bispecific Antibodies Recruiting Lymphocytic Effector Cells

  • Marta Compte,
  • Natalia Nuñez-Prado,
  • Laura Sanz and
  • Luis Alvarez-Vallina

27 June 2013

Engineered Fc-lacking bispecific antibodies have shown an exceptionally high potency for recruiting lymphocyte effector cells and enhancing antitumor activity, which is under evaluation in several clinical trials. However, current treatment regimens...

(This article belongs to the Special Issue Bispecific Antibodies for Dual Targeting Strategies)
  • Article
  • Open Access
11 Citations
11,275 Views
16 Pages

Monoclonal antibodies, engineered antibodies, and antibody fragments have become important biological therapeutic platforms. The IgG format with bivalent binding sites has a modular structure with different biological roles, i.e., effector and bindin...

(This article belongs to the Special Issue Biophysical Characterization and Molecular Engineering of Multidomain Proteins)
  • Article
  • Open Access
5 Citations
4,652 Views
13 Pages

Regulatory T Cell Depletion Using a CRISPR Fc-Optimized CD25 Antibody

  • Marit J. van Elsas,
  • Johan M. S. van der Schoot,
  • Alexander Bartels,
  • Kas Steuten and ,
  • Duco van Dalen,
  • Zacharias Wijfjes,
  • Carl G. Figdor,
  • Thorbald van Hall,
  • Sjoerd H. van der Burg and
  • Ferenc A. Scheeren
  • + 6 authors+ 1 author

Regulatory T cells (Tregs) are major drivers behind immunosuppressive mechanisms and present a major hurdle for cancer therapy. Tregs are characterized by a high expression of CD25, which is a potentially valuable target for Treg depletion to allevia...

(This article belongs to the Section Molecular Biology)
  • Article
  • Open Access
16 Citations
3,649 Views
14 Pages

A Recent SARS-CoV-2 Infection Enhances Antibody-Dependent Cellular Cytotoxicity against Several Omicron Subvariants following a Fourth mRNA Vaccine Dose

  • Guillaume Beaudoin-Bussières,
  • Alexandra Tauzin,
  • Katrina Dionne,
  • Gabrielle Gendron-Lepage and ,
  • Halima Medjahed,
  • Josée Perreault,
  • Inès Levade,
  • Laila Alfadhli,
  • Yuxia Bo and
  • Andrés Finzi
  • + 7 authors+ 2 authors

29 May 2023

Since the beginning of the SARS-CoV-2 pandemic, several variants of concern (VOCs), such as the Alpha, Beta, Gamma, Delta and Omicron variants, have arisen and spread worldwide. Today, the predominant circulating subvariants are sublineages of the Om...

(This article belongs to the Section SARS-CoV-2 and COVID-19)
  • Article
  • Open Access
8 Citations
6,450 Views
13 Pages

Complement Activation by an Anti-Dengue/Zika Antibody with Impaired Fcγ Receptor Binding Provides Strong Efficacy and Abrogates Risk of Antibody-Dependent Enhancement

  • Zenjiro Sampei,
  • Christine Xing’er Koo,
  • Frannie Jiuyi Teo,
  • Ying Xiu Toh and ,
  • Taku Fukuzawa,
  • Siok Wan Gan,
  • Takeru Nambu,
  • Adrian Ho,
  • Kiyofumi Honda and
  • Junichi Nezu
  • + 9 authors+ 4 authors

To combat infectious diseases, vaccines are considered the best prophylactic strategy for a wide range of the population, but even when vaccines are effective, the administration of therapeutic antibodies against viruses could provide further treatme...

(This article belongs to the Section Antibody Discovery and Engineering)
  • Review
  • Open Access
5 Citations
5,318 Views
17 Pages

Physiological and Pathophysiological Roles of IgM Fc Receptor (FcµR) Isoforms

  • Hiromi Kubagawa,
  • Caren Clark,
  • Christopher M. Skopnik,
  • Pedram Mahmoudi Aliabadi and ,
  • Khlowd Al-Qaisi,
  • Ruth Teuber,
  • Peter K. Jani,
  • Andreas Radbruch,
  • Fritz Melchers and
  • Jürgen Wienands
  • + 6 authors+ 1 author

IgM is the first antibody to emerge during phylogeny, ontogeny, and immune responses and serves as a first line of defense. Effector proteins interacting with the Fc portion of IgM, such as complement and its receptors, have been extensively studied...

(This article belongs to the Special Issue Fc Receptors 2.0)
  • Article
  • Open Access
16 Citations
7,241 Views
22 Pages

There Is Strength in Numbers: Quantitation of Fc Gamma Receptors on Murine Tissue-Resident Macrophages

  • Christof Vorsatz,
  • Niklas Friedrich,
  • Falk Nimmerjahn and
  • Markus Biburger

10 November 2021

Many of the effector functions of antibodies rely on the binding of antibodies/immune complexes to cellular Fcγ receptors (FcγRs). Since the majority of innate immune effector cells express both activating and inhibitory Fc receptors, the outcome of...

(This article belongs to the Special Issue Fc Receptors)
  • Article
  • Open Access
41 Citations
12,924 Views
10 Pages

Therapeutic antibodies have shifted the paradigm of disease treatments from small molecules to biologics, especially in cancer therapy. Despite the increasing number of antibody candidates, much remains unknown about the antibody and how its various...

(This article belongs to the Collection Computational Antibody and Antigen Design)
  • Article
  • Open Access
3 Citations
2,501 Views
13 Pages

Characterization of a Small Cysteine-Rich Secreted Effector, TcSCP_9014, in Tilletia controversa

  • Zhenzhen Du,
  • Han Weng,
  • Huanyu Jia,
  • Bin Zhang and ,
  • Boming Wu,
  • Wanquan Chen,
  • Taiguo Liu and
  • Li Gao
  • + 3 authors+ 0 author

31 May 2024

Tilletia controversa J. G. Kühn is the causal agent of wheat dwarf bunt (DB), a destructive disease causing tremendous economic losses. Small cysteine-rich secreted proteins (SCPs) of plant fungi are crucial in modulating host immunity and promo...

(This article belongs to the Section Plant Protection and Biotic Interactions)
  • Review
  • Open Access
72 Citations
12,021 Views
18 Pages

Multiple factors influence immunoglobulin G glycosylation, which in turn affect the glycoproteins’ function on eliciting an anti-inflammatory or pro-inflammatory response. It is prudent to underscore these processes when considering the use of immuno...

(This article belongs to the Section Biochemistry)
  • Article
  • Open Access
4 Citations
1,735 Views
13 Pages

Background: N-glycosylation is a post-translational modification involving the attachment of oligosaccharides to proteins and is known to influence immunoglobulin G (IgG) effector functions and even antigen binding. IgG contains an evolutionaril...

(This article belongs to the Special Issue Diabetes: Comorbidities, Therapeutics and Insights (2nd Edition))
  • Review
  • Open Access
9 Citations
31,632 Views
27 Pages

18 September 2024

Respiratory infections with respiratory syncytial virus (RSV) account for an important part of hospital admissions for acute respiratory infections. Nirsevimab has been developed to reduce the hospital burden of RSV infections. Compared with the prod...

(This article belongs to the Section Molecular Medicine)
  • Article
  • Open Access
787 Views
22 Pages

SsPit2A/B Effectors from Sporisorium scitamineum Interact with the Sugarcane PLCP ScRD21A and Reduce ScRD21A-Associated Cysteine Protease Activity via a Conserved LXRR Motif

  • Yangmin Zhu,
  • Zengrong Huang,
  • Junyi Wen,
  • Jiangming Wei and ,
  • Ke Liu,
  • Yuan Su,
  • Yunfeng Liu and
  • Shengchao Ge
  • + 3 authors+ 0 author

5 May 2026

Papain-like cysteine proteases (PLCPs) are central immune hubs frequently targeted by pathogen effectors. Sugarcane smut, caused by Sporisorium scitamineum, threatens global sugarcane yield, yet effector manipulation of host PLCPs remains unclear. Ge...

(This article belongs to the Section Plant Molecular Biology)
  • Review
  • Open Access
39 Citations
8,149 Views
27 Pages

Natural Killer Cells and Anti-Cancer Therapies: Reciprocal Effects on Immune Function and Therapeutic Response

  • Elisa C. Toffoli,
  • Abdolkarim Sheikhi,
  • Yannick D. Höppner,
  • Pita de Kok and ,
  • Mahsa Yazdanpanah-Samani,
  • Jan Spanholtz,
  • Henk M. W. Verheul,
  • Hans J. van der Vliet and
  • Tanja D. de Gruijl
  • + 4 authors+ 0 author

9 February 2021

Natural Killer (NK) cells are innate immune cells with the unique ability to recognize and kill virus-infected and cancer cells without prior immune sensitization. Due to their expression of the Fc receptor CD16, effector NK cells can kill tumor cell...

(This article belongs to the Special Issue Challenges and Opportunities for Effective Cancer Immunotherapies)
  • Article
  • Open Access
9 Citations
4,326 Views
27 Pages

Characterization of an In Vivo Neutralizing Anti-Vaccinia Virus D8 Single-Chain Fragment Variable (scFv) from a Human Anti-Vaccinia Virus-Specific Recombinant Library

  • Ulrike S. Diesterbeck,
  • Henrike P. Ahsendorf,
  • André Frenzel,
  • Ahmad Reza Sharifi and ,
  • Thomas Schirrmann and
  • Claus-Peter Czerny
  • + 1 author+ 0 author

10 November 2021

A panel of potent neutralizing antibodies are protective against orthopoxvirus (OPXV) infections. For the development of OPXV-specific recombinant human single-chain antibodies (scFvs), the IgG repertoire of four vaccinated donors was amplified from...

(This article belongs to the Section Vaccines Against Tropical and Other Infectious Diseases)
  • Review
  • Open Access
47 Citations
10,549 Views
13 Pages

3D Structures of IgA, IgM, and Components

  • Shunli Pan,
  • Noriyoshi Manabe and
  • Yoshiki Yamaguchi

26 November 2021

Immunoglobulin G (IgG) is currently the most studied immunoglobin class and is frequently used in antibody therapeutics in which its beneficial effector functions are exploited. IgG is composed of two heavy chains and two light chains, forming the ba...

(This article belongs to the Section Molecular Biophysics)
  • Article
  • Open Access
11 Citations
4,560 Views
12 Pages

The Conserved Effector UvHrip1 Interacts with OsHGW and Infection of Ustilaginoidea virens Regulates Defense- and Heading Date-Related Signaling Pathway

  • Songhong Wei,
  • Yingling Wang,
  • Jianming Zhou,
  • Shibo Xiang and ,
  • Wenxian Sun,
  • Xunwen Peng,
  • Jing Li,
  • Yingfan Hai,
  • Yan Wang and
  • Shuai Li
  • + 5 authors+ 0 author

Ustilaginoidea virens, which causes rice false smut (RFS), is one of the most detrimental rice fungal diseases and poses a severe threat to rice production and quality. Effectors in U. virens often act as a group of essential virulence factors that p...

(This article belongs to the Section Molecular Biology)
  • Review
  • Open Access
10 Citations
5,922 Views
14 Pages

1 March 2020

The constant region of immunoglobulin (Ig) G antibodies is responsible for their effector immune mechanism and prolongs serum half-life, while the fragment variable (Fv) region is responsible for cellular or tissue targeting. Therefore, antibody engi...

(This article belongs to the Special Issue Advances in Antibody Therapy of Cancer)
  • Review
  • Open Access
128 Citations
32,852 Views
20 Pages

The development of recombinant therapeutic proteins has been a major revolution in modern medicine. Therapeutic-based monoclonal antibodies (mAbs) are growing rapidly, providing a potential class of human pharmaceuticals that can improve the manageme...

(This article belongs to the Special Issue Monoclonal Antibody-Directed Therapy)
  • Article
  • Open Access
9 Citations
4,737 Views
22 Pages

Macrophages Impair TLR9 Agonist Antitumor Activity through Interacting with the Anti-PD-1 Antibody Fc Domain

  • Simone Camelliti,
  • Valentino Le Noci,
  • Francesca Bianchi,
  • Chiara Storti and ,
  • Francesca Arnaboldi,
  • Alessandra Cataldo,
  • Serena Indino,
  • Elena Jachetti,
  • Mariangela Figini and
  • Michele Sommariva
  • + 10 authors+ 5 authors

13 August 2021

Background. A combination of TLR9 agonists and an anti-PD-1 antibody has been reported to be effective in immunocompetent mice but the role of innate immunity has not yet been completely elucidated. Therefore, we investigated the contribution of the...

(This article belongs to the Special Issue Immunotherapy: New Prospective in the Treatment of Ovarian Cancer)
  • Review
  • Open Access
337 Views
13 Pages

Bruton Tyrosine Kinase Inhibitors in Immune-Mediated Skin Diseases: Current Evidence and Future Directions

  • Zihan Wang,
  • Junchen He,
  • Ting Zhang,
  • Jiayu Peng and ,
  • Lulu Xie,
  • Bingrun Li,
  • Cunhao Shan,
  • Litao Zhang and
  • Zuotao Zhao
  • + 4 authors+ 0 author

21 October 2026

Bruton tyrosine kinase (BTK) is a central signaling molecule that links the B-cell receptor (BCR), Fc receptors, and Toll-like receptors (TLRs). By coordinating signaling in B cells, mast cells, macrophages, and other immune cells, BTK occupies an im...

(This article belongs to the Special Issue Advances in Autoimmune Diseases: The Molecular Basis and New Therapies)
  • Article
  • Open Access
28 Citations
8,938 Views
15 Pages

22 January 2020

Antibody-dependent cell-mediated cytotoxicity (ADCC) and complement-dependent cytotoxicity (CDC) are involved in destruction of thyroid tissue in Hashimoto’s thyroiditis (HT). N-glycosylation of the Fc fragment affects the effector functions of...

(This article belongs to the Special Issue Molecular Basis of Autoimmunity Diseases)
  • Review
  • Open Access
10 Citations
5,072 Views
25 Pages

Neutralizing Antibodies vs. Viruses: Interacting Mechanisms and Escape Tactics

  • Hao Lu,
  • Yichen Liu,
  • Yue Song,
  • Longxin Chen and ,
  • Limeng Zhang,
  • Runting Li,
  • Xiaoning Nie,
  • Guoqiang Zhu,
  • Xueyan Ding and
  • Linqing Wang
  • + 5 authors+ 0 author

Virus-neutralizing antibodies (VNAs) serve as critical components of host immune defense, countering viral infections by specifically recognizing epitopes on viral surface antigens to block viral entry and replication. This review elucidates the func...

(This article belongs to the Section Molecular Microbiology and Immunology)
  • Article
  • Open Access
5 Citations
4,073 Views
24 Pages

The Therapeutic Monoclonal Antibody Bamlanivimab Does Not Enhance SARS-CoV-2 Infection by FcR-Mediated Mechanisms

  • Robert W. Cross,
  • Christopher M. Wiethoff,
  • Patricia Brown-Augsburger,
  • Shawn Berens and ,
  • Jamie Blackbourne,
  • Ling Liu,
  • Xiaohua Wu,
  • Jonathan Tetreault,
  • Carter Dodd and
  • Thomas W. Geisbert
  • + 25 authors+ 20 authors

30 November 2023

As part of the non-clinical safety package characterizing bamlanivimab (SARS-CoV-2 neutralizing monoclonal antibody), the risk profile for antibody-dependent enhancement of infection (ADE) was evaluated in vitro and in an African green monkey (AGM) m...

(This article belongs to the Section Viral Pathogens)
  • Review
  • Open Access
2,529 Views
15 Pages

IgG4 is an unusual immunoglobulin (Ig) and is the least component of IgG in humans. It is often asymmetrical and heterobivalent with weak Fc (fragment crystallizable region)-dependent effector function and ineffective complement activation, thus play...

  • Review
  • Open Access
102 Views
25 Pages

12 November 2026

Latent tuberculosis infection (LTBI) is the main reservoir of active tuberculosis (ATB), yet the molecular mechanisms underlying its progression to active disease remain incompletely understood. As a key post-translational modification, glycosylation...

  • Article
  • Open Access
3 Citations
2,232 Views
15 Pages

Enhancement of Protein–Protein Interactions by Destabilizing Mutations Revealed by HDX-MS

  • Yoshitomo Hamuro,
  • Anthony Armstrong,
  • Jeffrey Branson,
  • Sheng-Jiun Wu and ,
  • Richard Y.-C. Huang and
  • Steven Jacobs
  • + 1 author+ 0 author

20 August 2025

Enhancing protein–protein interactions is a key therapeutic strategy to ensure effective protein function in terms of pharmacokinetics and pharmacodynamics and can be accomplished with methods like directed evolution or rationale design. Previo...

(This article belongs to the Section Molecular Biology)
  • Article
  • Open Access
2 Citations
3,061 Views
14 Pages

Local Immune Activation and Age Impact on Humoral Immunity in Mice, with a Focus on IgG Sialylation

  • Priti Gupta,
  • Tibor Sághy,
  • Miriam Bollmann,
  • Tao Jin and ,
  • Claes Ohlsson,
  • Hans Carlsten,
  • Carmen Corciulo and
  • Cecilia Engdahl
  • + 3 authors+ 0 author

29 April 2024

Age alters the host’s susceptibility to immune induction. Humoral immunity with circulating antibodies, particularly immunoglobulin G (IgG), plays an essential role in immune response. IgG glycosylation in the fragment crystallizable (Fc) regio...

(This article belongs to the Section Vaccines, Clinical Advancement, and Associated Immunology)
  • Communication
  • Open Access
2 Citations
2,579 Views
12 Pages

NTB-A and 2B4 Natural Killer Cell Receptors Modulate the Capacity of a Cocktail of Non-Neutralizing Antibodies and a Small CD4-Mimetic to Eliminate HIV-1-Infected Cells by Antibody-Dependent Cellular Cytotoxicity

  • Lorie Marchitto,
  • Alexandra Tauzin,
  • Mehdi Benlarbi,
  • Guillaume Beaudoin-Bussières and ,
  • Katrina Dionne,
  • Étienne Bélanger,
  • Debashree Chatterjee,
  • Catherine Bourassa,
  • Halima Medjahed and
  • Andrés Finzi
  • + 10 authors+ 5 authors

20 July 2024

Natural Killer (NK) cells have the potential to eliminate HIV-1-infected cells by antibody-dependent cellular cytotoxicity (ADCC). NK cell activation is tightly regulated by the engagement of its inhibitory and activating receptors. The activating re...

(This article belongs to the Special Issue Natural Killer Cell in Viral Infection)
  • Article
  • Open Access
8 Citations
2,456 Views
19 Pages

Immunoglobulin G Subclass-Specific Glycosylation Changes in Rheumatoid Arthritis

  • Dániel Szabó,
  • Balázs Gyebrovszki,
  • Eszter Szarka,
  • Felícia Auer and ,
  • Bernadette Rojkovich,
  • György Nagy,
  • András Telekes,
  • Károly Vékey,
  • László Drahos and
  • Gabriella Sármay
  • + 6 authors+ 1 author

2 October 2025

Rheumatoid arthritis (RA) is the most common inflammatory polyarthritis. In addition, 60–80% of patients express anti-citrullinated protein antibodies (ACPAs), which serve as a diagnostic marker for RA. The effector functions of these autoantib...

(This article belongs to the Section Molecular Pathology, Diagnostics, and Therapeutics)
  • Review
  • Open Access
1 Citations
2,035 Views
19 Pages

Venezuelan Equine Encephalitis Virus: Structural Biology, Vaccines, and Advances in Functional Antibodies

  • Rui Tang,
  • Daojing Wang,
  • Guojiang Chen,
  • Chenghua Liu and ,
  • Liang Zhang,
  • Fenghao Peng,
  • Jijun Yu,
  • Xinying Li,
  • Heng Luo and
  • Chunxia Qiao
  • + 6 authors+ 1 author

24 December 2025

Background: Venezuelan equine encephalitis virus (VEEV) poses a significant public health and biodefense threat due to periodic epidemics of severe neurological disease in the Americas, yet no licensed human vaccines or specific antiviral therapies e...

(This article belongs to the Section Pathogens-Host Immune Boundaries)
  • Commentary
  • Open Access
11 Citations
10,663 Views
9 Pages

3 February 2021

The possible interplay between autoimmunity and cancer is a topic that still needs to be deeply explored. Rheumatoid factors are autoantibodies that are able to bind the constant regions (Fc) of immunoglobulins class G (IgGs). In physiological condit...

(This article belongs to the Special Issue Cancer Biomarkers in Body Fluids)
  • Review
  • Open Access
55 Citations
10,028 Views
14 Pages

Nanobodies that Neutralize HIV

  • Robin A. Weiss and
  • C. Theo Verrips

Nanobodies or VHH (variable domains of heavy-chain only antibodies) are derived from camelid species such as llamas and camels. Nanobodies isolated and selected through phage display can neutralize a broad range of human immunodeficiency virus type 1...

(This article belongs to the Special Issue Advances in Antibody-based HIV-1 Vaccine Development)
  • Article
  • Open Access
3 Citations
2,629 Views
15 Pages

Characterization of O-Glycosylation and N-Glycosylation in Bispecific Antibodies and Its Importance in Therapeutic Antibody Development

  • Maoqin Duan,
  • Luyun Guo,
  • Zhen Long,
  • Yongbo Ni and ,
  • Yalan Yang,
  • Jialiang Du,
  • Meng Li,
  • Jialing Zhang,
  • Tao Tang and
  • Lan Wang
  • + 6 authors+ 1 author

13 October 2025

Background/Objectives: This study comprehensively characterized the O- and N-glycosylation profiles of bispecific antibodies (BsAbs) via advanced analytical techniques to evaluate their structural and functional implications. Methods: High-resolution...

(This article belongs to the Section Biopharmaceuticals)
  • Article
  • Open Access
10 Citations
4,909 Views
12 Pages

Differences between Human and Mouse IgM Fc Receptor (FcµR)

  • Hiromi Kubagawa,
  • Christopher M. Skopnik,
  • Khlowd Al-Qaisi,
  • Rosaleen A. Calvert and ,
  • Kazuhito Honjo,
  • Yoshiki Kubagawa,
  • Ruth Teuber,
  • Pedram Mahmoudi Aliabadi,
  • Philipp Enghard and
  • Brian J. Sutton
  • + 6 authors+ 1 author

Both non-immune “natural” and antigen-induced “immune” IgM are important for protection against pathogens and for regulation of immune responses to self-antigens. Since the bona fide IgM Fc receptor (FcµR) was identified in humans by a functional clo...

(This article belongs to the Special Issue Fc Receptors)
  • Review
  • Open Access
69 Citations
15,985 Views
21 Pages

With the development of molecular cloning technology and the deep understanding of antibody engineering, there are diverse bispecific antibody formats from which to choose to pursue the optimal biological activity and clinical purpose. The single-cha...

(This article belongs to the Section Molecular Pathology, Diagnostics, and Therapeutics)
  • Article
  • Open Access
271 Views
22 Pages

9 October 2026

Amphibian skin relies on secreted effectors and inducible immune pathways, but short-read RNA sequencing cannot reliably resolve the transcript isoforms and precursor structures underlying this defense system. We generated the first full-length skin...

(This article belongs to the Section Immunology)
  • Article
  • Open Access
3 Citations
3,920 Views
10 Pages

Quantitative Visualization of the Interaction between Complement Component C1 and Immunoglobulin G: The Effect of CH1 Domain Deletion

  • Saeko Yanaka,
  • Shigetaka Nishiguchi,
  • Rina Yogo,
  • Hiroki Watanabe and ,
  • Jiana Shen,
  • Hirokazu Yagi,
  • Takayuki Uchihashi and
  • Koichi Kato
  • + 3 authors+ 0 author

14 February 2022

Immunoglobulin G (IgG) adopts a modular multidomain structure that mediates antigen recognition and effector functions, such as complement-dependent cytotoxicity. IgG molecules are self-assembled into a hexameric ring on antigen-containing membranes,...

(This article belongs to the Special Issue Biophysical Characterization and Molecular Engineering of Multidomain Proteins 2.0)
  • Article
  • Open Access
2 Citations
5,286 Views
19 Pages

Development of a Bispecific IgG1 Antibody Targeting BCMA and PDL1

  • Irene Cattaneo,
  • Sylvie Choblet,
  • Rut Valgardsdottir,
  • Muriel Roth and ,
  • Annamaria Massafra,
  • Marten Beeg,
  • Marco Gobbi,
  • Martine Duonor-Cerutti and
  • Josée Golay
  • + 4 authors+ 0 author

20 February 2024

We designed, produced, and purified a novel IgG1-like, bispecific antibody (bsAb) directed against B-cell maturation antigen (BCMA), expressed by multiple myeloma (MM) cells, and an immune checkpoint inhibitor (ICI), PDL1, expressed in the MM microen...

(This article belongs to the Section Antibody-Based Therapeutics)
  • Review
  • Open Access
32 Citations
7,845 Views
23 Pages

Promising Antigens for the New Frontier of Targeted Immunotherapy in Multiple Myeloma

  • Shih-Feng Cho,
  • Lijie Xing,
  • Kenneth C. Anderson and
  • Yu-Tzu Tai

6 December 2021

The incorporation of novel agents in recent treatments in multiple myeloma (MM) has improved the clinical outcome of patients. Specifically, the approval of monoclonal antibody (MoAb) against CD38 (daratumumab) and SLAMF7 (elotuzumab) in relapsed and...

(This article belongs to the Special Issue Signaling Pathways in Multiple Myeloma)
  • Article
  • Open Access
9 Citations
3,869 Views
25 Pages

TGFβ Inhibitor A83-01 Enhances Murine HSPC Expansion for Gene Therapy

  • Jenni Fleischauer,
  • Antonella Lucia Bastone,
  • Anton Selich,
  • Philipp John-Neek and ,
  • Luisa Weisskoeppel,
  • Dirk Schaudien,
  • Axel Schambach and
  • Michael Rothe
  • + 3 authors+ 0 author

31 July 2023

Murine hematopoietic stem and progenitor cells (HSPCs) are commonly used as model systems during gene therapeutic retroviral vector development and preclinical biosafety assessment. Here, we developed cell culture conditions to maintain stemness and...

(This article belongs to the Special Issue Gene and Cell Therapy in Regenerative Medicine)
  • Review
  • Open Access
5 Citations
6,355 Views
23 Pages

Nucleic Acid Vaccines Encoding Proteins and Virus-like Particles for HIV Prevention

  • Ferran Tarrés-Freixas,
  • Bonaventura Clotet,
  • Jorge Carrillo and
  • Julià Blanco

12 March 2024

The development of HIV prophylactic vaccines is facing an impasse, since all phase IIb/III clinical trials were halted in 2023 without demonstrating efficacy. Thus, the field is in need of developing novel immunogens and vaccination strategies that i...

(This article belongs to the Special Issue Feature Papers of DNA and mRNA Vaccines)

of 3